About ZyCoV-D®
ZyCoV-D® is the world’s first plasmid DNA vaccine for human use that has been developed in India and given restricted use license for emergency situation that grants permission for the vaccine to be used for active immunization of individuals aged 12 years and older for the prevention of coronavirus disease 2019 (COVID-19).1-4
ZyCoV-D® vaccination schedule consists of 3 separate doses to be given at an interval of 28 days each (day 0, day 28 and day 56).Each dose consists of two shots of 0.1ml each given by needle-free injector (PharmaJet Tropis device) via intradermal route at two separate sites (preferably deltoid region of both the arms).4
Key Features of ZyCoV-D®
DNA vaccine for COVID-191
approved for individuals
aged 12 years and above 4
(PharmaJet Tropis device)4
shown efficacy of 66.6%
in interim analysis 5
and developed in India as
part of the Atmanirbhar
Bharat mission
World’s First Plasmid DNA Vaccine for COVID-19 – ZyCoV-D®
Conversations
Trending News
India’s DNA COVID vaccine is a world first – more are coming
India has approved a new COVID-19 vaccine that uses circular strands of DNA to prime the immune system against the virus SARS-CoV-2.
Read More
Why AIIMS Chief Thinks Zydus Cadila DNA Vaccine Is A Boost For India
The Zydus Cadila vaccine is the first DNA shot against COVID-19 approved in the world, AIIMS chief Dr Randeep Guleria ..
Read More
ZyCoV-D® vaccine safe and effective for adolescents, says expert
Dr. N.K. Arora, a senior member of National COVID-19 Task Force and Advisor, national AEFI committee…
Read More
Zydus Cadila's needle-free COVID-19 vaccine, ZyCoV-D®, gets approval in India
The Indian drug regulator’s subject expert committee has recommended approving Zydus Cadila’s three-dose COVID-19 vaccine
Read More
Modi at UNGA: PM announces world's first DNA vaccine for COVID-19 from..
Prime Minister Narendra Modi on Saturday announced the world’s first DNA vaccine against coronavirus disease (COVID-19) from…
Read More
India first to develop DNA vaccine, can be administered to 12 and above..
DNA vaccine, can be administered to 12 and above: PM Modi at UNGA … arrives to address the 76th Session of the U.N. General Assembly…
Read More
From nasal vaccines to rubbing Pakistan's nose: Key highlights of...
From nasal vaccines to rubbing Pakistan’s nose: Key highlights of PM the UNGA that India has developed the world’s first DNA vaccine
Read More
India Has Developed First DNA Vaccine, Can Be Given To Those Above 12: PM
India has developed the world’s first DNA vaccine that can be given to everyone above 12 years of age, Prime Minister Narendra Modi…
Read More
First-ever DNA vaccine developed in India, can be administered to those....
During his address in the UNGA session 2021, PM Modi said that India has developed the world’s first DNA vaccine which will advance…
Read More
PM Modi at UNGA invites global manufacturers to come and make..
I want to inform UNGA that India has developed the world’s first DNA vaccine, which can be administered to all people…
Read More
Jagran Explainer | What is ZyCoV-D®, world's first DNA vaccine....
ZyCoV-D: Prime Minister Narendra Modi in his speech at UNGA announced the world’s first DNA vaccines…
Read More
PM Modi uses Rabindranath Tagore`s words to end UN General....
Also read | PM Modi at UNGA: Covid taught world that global … Also read | India is first to develop….
Read More
PM Modi UNGA Address 2021: India has developed the world's first...
During his address at the 76th UNGA session, Prime Minister Narendra Modi said that “India has developed …
Read More
DNA Explainer: Why New York City rules are not applicable on UN building?
US is bound by the UNGA charter and so it has to relax its vaccine norms for the head of state….
Read More
ZyCoV-D® is a platform for the future, says Zydus Cadila MD Sharvil Patel
Our original plan was to release it in October. Now we are waiting for the pricing approval. It is more complicated because ….
Read More
India becomes first country in world to administer COVID-19 DNA vaccine
The Indian government approved emergency use authorisation for Zydus Cadila’s DNA vaccine earlier this year, citing initial results from Phase III clinical trials that showed approximately 66 percent ….
Read More
Zydus Cadila supplies first consignment of its Covid vaccine ZyCoV-D® to govt
Zydus Cadila announced that it has supplied the first consignment of its Covid-19 vaccine, ZyCoV-D®, to the government. The vaccine will be priced at Rs 265 per dose ….
Read More
Zydus Vaccines – Heritage Across Decades
About Zydus Cadila
Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of healthcare therapies including small molecule drugs, biologic therapeutics, and vaccines. The group employs 25,000 people worldwide and is dedicated to creating healthier communities globally. For more information, please visit www.zyduscadila.com
Zydus’ multi-pronged approach to combat the COVID-19 pandemic
(June, 2020)
(August, 2020)
mouth spray that forms
a protective layer in the
throat which reduces
the virus load by 99%, Viroshield (April, 2021)
for the prevention of COVID-19, ZyCoV-D
(August, 2021)
ICMR-NIV Pune, COVID KAVACH ELISA
(May, 2020)
for home use,
ZyOxy (July,2020)
Zydus Hospital
Dahod, Gujarat
Zydus’ Vaccine Research Program
Vaccine Technology Centre of Zydus Cadila has wide range of capabilities in developing and manufacturing viral, toxoid, polysaccharide, conjugate and other subunit vaccines for unmet needs.
In fact, Zydus was the first company in India to develop and indigenously manufacture the vaccine to combat Swine Flu during the pandemic in 2010. In past, it has also indigenously developed numerous vaccines successfully including tetravalent seasonal influenza vaccine (first company in India to indigenously develop and commercialize), Inactivated Rabies vaccine (WHO Prequalified), Varicella vaccine (first Indian company to indigenously develop and receive market authorization), Measles containing vaccines (MR, MMR), Typhoid conjugate vaccine, pentavalent vaccine (DPT-HepB-Hib) to name a few.